LGP2变异对MDA5介导的干扰素反应激活及丁型肝炎病毒复制抑制的影响
本研究在丁型肝炎病毒(HDV)易感的HepaRGNTCP细胞和原代人肝细胞中敲低RIG-I样受体并回补不同LGP2版本,发现LGP2对HDV感染诱导的MDA5介导干扰素反应不可或缺,且该诱导需LGP2的RNA结合与ATP酶活性;干扰素反应仅中度减少静息细胞中HDV复制,却深度抑制细胞分裂介导的HDV扩散;Q425R LGP2变异体介导更高的基础及更快的HDV诱导干扰素反应和更强HDV抑制。
要点
- LGP2是HDV感染诱导MDA5介导干扰素反应所必需,且需其RNA结合与ATP酶活性。
- 干扰素反应仅中度减少静息细胞中HDV复制,但深度抑制细胞分裂介导的HDV扩散。
- Q425R LGP2变异体介导更高基础及更快HDV诱导干扰素反应和更强HDV抑制。
核心结论
- LGP2对HDV诱导的抗病毒干扰素反应不可或缺,并稳定MDA5-RNA相互作用以支持下游信号传导。
- 天然Q425R LGP2为功能获得性变异体,可能有助于丁型肝炎病程减轻。
研究设计与样本
- 在HDV易感的HepaRGNTCP细胞和原代人肝细胞中敲低RIG-I样受体,并回补表达不同LGP2版本。
- 以时间分辨方式定量HDV和干扰素标志物,并通过pull-down实验研究LGP2、MDA5与RNA间的相互作用。
主要发现
- LGP2为HDV感染诱导的MDA5介导干扰素反应所必需,该诱导需LGP2的RNA结合与ATP酶活性。
- 干扰素反应仅中度减少静息细胞中HDV复制,但深度抑制细胞分裂介导的HDV扩散。
- Q425R LGP2变异体介导可检测到更高的基础干扰素反应、更快的HDV诱导干扰素反应及更强的HDV抑制。
- LGP2的RNA结合是形成稳定MDA5-RNA复合物的前提,Q425R LGP2变异体增强MDA5与RNA结合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Retinoic acid inducible gene I (RIG-I)-like receptors (RLRs), including RIG-I, melanoma differentiation-associated protein 5 (MDA5), and laboratory of genetics and physiology 2 (LGP2), sense viral RNA to induce the antiviral interferon (IFN) response. LGP2, unable to activate the IFN response itself, modulates RIG-I and MDA5 signalling. HDV, a small RNA virus causing the most severe form of viral hepatitis, is sensed by MDA5. The mechanism underlying IFN induction and its effect on HDV replication is unclear. Here, we aimed to unveil the role of LGP2 and clinically relevant variants thereof in these processes. METHODS: RLRs were depleted in HDV susceptible HepaRGNTCP cells and primary human hepatocytes. Cells were reconstituted to express different LGP2 versions. HDV and IFN markers were quantified in a time-resolved manner. Interaction studies among LGP2, MDA5, and RNA were performed by pull-down assays. RESULTS: LGP2 is essential for the MDA5-mediated IFN response induced upon HDV infection. This induction requires both RNA binding and ATPase activities of LGP2. The IFN response only moderately reduced HDV replication in resting cells but profoundly suppressed cell division-mediated HDV spread. An LGP2 variant (Q425R), predominating in Africans who develop less severe chronic hepatitis D, mediated detectably higher basal and faster HDV-induced IFN response as well as stronger HDV suppression. Mechanistically, LGP2 RNA binding was a prerequisite for the formation of stable MDA5-RNA complexes. MDA5 binding to RNA was enhanced by the Q425R LGP2 variant. CONCLUSIONS: LGP2 is essential to mount an antiviral IFN response induced by HDV and stabilises MDA5-RNA interaction required for downstream signalling. The natural Q425R LGP2 is a gain-of-function variant and might contribute to an attenuated course of hepatitis D. IMPACT AND IMPLICATIONS: HDV is the causative pathogen of chronic hepatitis D, a severe form of viral hepatitis that can lead to cirrhosis and hepatocellular carcinoma. Upon infection, the human immune system senses HDV and mounts an antiviral interferon (IFN) response. Here, we demonstrate that the immune sensor LGP2 cooperates with MDA5 to mount an IFN response that represses HDV replication. We mapped LGP2 determinants required for IFN system activation and characterised several natural genetic variants of LGP2. One of them reported to predominate in sub-Saharan Africans can accelerate HDV-induced IFN responses, arguing that genetic determinants, possibly including LGP2, might contribute to slower disease progression in this population. Our results will hopefully prompt further studies on genetic variations in LGP2 and other components of the innate immune sensing system, including assessments of their possible impact on the course of viral infection.
引用
- Gillich N, Zhang Z, Binder M, et al. Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication. J Hepatol. 2022. PMID: 36152765. doi:10.1016/j.jhep.2022.08.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。